Premium
P2‐039: PROGRESS OF THE PHASE I CLINICAL TRIAL TO EVALUATE LONGEVERON ALLOGENEIC MESENCHYMAL STEM CELLS (LMSCS) AS A POTENTIAL THERAPEUTIC FOR ALZHEIMER'S DISEASE
Author(s) -
Oliva Anthony A.,
Baumel Bernard,
Brody Mark,
Agronin Marc,
Drouillard Amy,
Pena Andrea,
McClain-Moss Lisa,
Page Suzanne L.,
Perez Carmen,
Landman Jonathan,
Alston Tequesta,
Bookheimer Susan Y.,
Castaneda Ricardo,
Hare Joshua M.
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.1261
Subject(s) - medicine , mesenchymal stem cell , clinical trial , placebo , disease , oncology , pathology , alternative medicine